[ad_1] BEIJING–(BUSINESS WIRE)–Mar 9, 2023– InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of…
Read More »[ad_1] BEIJING–(BUSINESS WIRE)–Mar 9, 2023– InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of…
Read More »